サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1420138

中南米のオルガノイド市場の2030年までの予測- 地域別分析- 臓器タイプ、用途、供給源、タイプ別

South & Central America Organoids Market Forecast to 2030 - Regional Analysis - by Organ Type, Application, Source, and Type

出版日
ページ情報
英文 82 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
中南米のオルガノイド市場の2030年までの予測- 地域別分析- 臓器タイプ、用途、供給源、タイプ別
出版日: 2023年11月29日
発行: The Insight Partners
ページ情報: 英文 82 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米のオルガノイド市場は、2022年の1億3,238万米ドルから2030年には6億5,425万米ドルに成長すると予測されています。2022年から2030年までのCAGRは22.1%と推定されます。

創薬活動への注力が中南米のオルガノイド市場を後押し

新薬・先端薬への需要の高まりが、創薬・研究全体のペースを押し上げています。ClinicalTrials.govによると、2020年の臨床試験総数は356,282件と推定されています。Hubrecht研究所の最近の調査によると、オルガノイドは、その薬剤の恩恵を受けそうにない患者を特定することで、高価な薬剤の費用対効果を高める可能性があるとしています。世界の臨床試験の増加は、オルガノイドモデルを含む先端医療技術の需要を促進すると予想されています。

さらに、創薬におけるオルガノイドはがんだけに限らず、嚢胞性線維症、多発性嚢胞腎、小頭症、腸や気道の感染症など、他の疾患でも使用されています。例えば、オルガノイドは臓器の構造や機能など、臓器の特性を要約することができます。また、オルガノイドは組織や臓器の本来の遺伝的・エピジェネティックな状態を復元できるため、遺伝子編集に適しています。様々な研究が、CRISPR-Cas9技術とオルガノイドの組み合わせによる良好な結果を示しており、嚢胞性線維症におけるブレークスルーの機会を広げています。2020年に発表された研究「CRISPR-Based Adenine Editors Correct Nonsense Mutation in a Cystic Fibrosis Organoid Biobank」によると、嚢胞性線維症腸管オルガノイドのバイオバンクは664人の患者を代表し、そのうちの～20％がアデニン塩基エディターによって嚢胞性線維症膜貫通型伝導体受容体のナンセンス変異を理論的に効率よく修復することができました。いくつかの動物モデルで遺伝子編集オルガノイドの成果はあるもの、その効率は著しく低く、成功率は高くないです。したがって、遺伝子編集オルガノイドの安全性、長期安定性、機能性のためのプロセスの研究開発は極めて重要です。

さらに、COVID-19のパンデミックは、ヒト肺オルガノイドモデルを開発する必要性を引き起こしました。例えば、ミリポア・シグマ社は3dGROヒト肺オルガノイド培養システムを開発しました。このシステムは、研究者がヒト肺上皮のオルガノイドモデルを培養するための臓器組織を制御し、アクセスし、再現することを可能にし、研究中に肯定的で成功した結果を得るのに役立ちます。したがって、このような技術革新は市場成長にとってより大きな成長機会を提供すると期待されます。

中南米のオルガノイド市場概要

中南米のオルガノイド市場は、ブラジル、アルゼンチン、その他中南米に区分されます。この地域の市場は、がん患者の増加、政府のイニシアチブの高まり、オルガノイドの研究開発の高まりによって成長すると期待されています。

中南米のオルガノイド市場の収益と2030年までの予測（金額）

中南米のオルガノイド市場セグメンテーション

中南米のオルガノイド市場は、臓器タイプ、用途、供給源、国に区分されます。

臓器タイプに基づき、中南米のオルガノイド市場は腸、肝臓、胃、膵臓、肺、脳、腎臓、その他に区分されます。腸セグメントが2022年の中南米のオルガノイド市場で最大のシェアを占めました。

タイプ別に見ると、中南米のオルガノイド市場は器具、消耗品、サービスに区分されます。消耗品セグメントは2022年に北米オルガノイド市場で最大のシェアを占めました。

用途別では、中南米のオルガノイド市場は発生生物学疾患、感染症病理学、再生医療、薬物毒性・有効性試験、創薬・個別化医療、その他に区分されます。2022年の中南米のオルガノイド市場では、発生生物学疾患分野が最大シェアを占めました。

供給源に基づいて、中南米のオルガノイド市場は多能性幹細胞と臓器特異的成体幹細胞に二分されます。2022年の中南米のオルガノイド市場では、多能性幹細胞分野が大きなシェアを占めています。

国別に見ると、中南米のオルガノイド市場はブラジル、アルゼンチン、その中他南米に区分されます。2022年の中南米のオルガノイド市場はブラジルが独占。

Cellsce社、InSphero社、Merck KGaA社、STEMCELL Technologies Inc社、Thermo Fisher Scientific Inc社は、中南米のオルガノイド市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 中南米主要洞察
  • 中南米市場の魅力

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米のオルガノイド市場情勢

  • 概観
  • 中南米のPEST分析

第5章 中南米のオルガノイド市場：主要産業力学

  • 主な市場促進要因
    • 腫瘍モデリングとバイオバンクの需要増加
    • 個別化医薬品の採用拡大
    • 動物実験モデルの代替品開発への注目の高まり
  • 主な市場抑制要因
    • 既存のワークフローへのオルガノイドの組み込みに関する問題
    • 熟練した専門家の不足
  • 主な市場機会
    • 創薬活動の重視
  • 今後の動向
    • オルガノイドとOrgan-On-A-Chipの組み合わせ
  • 影響分析

第6章 オルガノイド市場：中南米市場分析

  • 中南米のオルガノイド市場収益、2022年～2030年

第7章 中南米のオルガノイド市場：収益と2030年までの予測：臓器タイプ別

  • 中南米のオルガノイド市場2022年・2030年臓器タイプ別収益シェア（%）
  • 胃
  • 腸
  • 肝臓
  • 膵臓
  • 肺
  • 脳
  • 腎臓
  • その他

第8章 中南米のオルガノイド市場：収益と2030年までの予測：用途別

  • 中南米のオルガノイド市場2022年・2030年用途別収益シェア（%）
  • 発生生物学
  • 感染症病態学
  • 再生医療
  • 薬物毒性および有効性試験
  • 創薬と個別化医療
  • その他

第9章 中南米のオルガノイド市場：収益と2030年までの予測：供給源別

  • 中南米のオルガノイド市場2022年・2030年供給源別収益シェア（%）
  • 多能性幹細胞
  • 臓器特異的成体幹細胞

第10章 中南米のオルガノイド市場：収益と2030年までの予測：タイプ別

  • 中南米のオルガノイド市場2022年および2030年タイプ別収益シェア（%）
  • 機器
  • 消耗品
  • サービス

第11章 中南米のオルガノイド市場：国別分析

  • 中南米のオルガノイド市場
    • ブラジル
    • アルゼンチン
    • その他中南米

第12章 COVID-19前後の影響

  • COVID-19前後の影響

第13章 中南米のオルガノイド市場業界情勢

  • 市場参入企業の成長戦略（%）
  • 有機開発
  • 無機開発

第14章 中南米のオルガノイド市場：主要企業プロファイル

  • STEMCELL Technologies Inc.
  • Cellesce Ltd
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • InSphero

第15章 付録

図表

List Of Tables

  • Table 1. South & Central America Organoids Market Segmentation
  • Table 2. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 3. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 4. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 5. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 6. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 7. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 8. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 9. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 10. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 11. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 12. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 13. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 14. Organic Developments Done by Companies
  • Table 15. Inorganic Developments Done by Companies
  • Table 16. Glossary of Terms, South & Central America Organoids Market

List Of Figures

  • Figure 1. South & Central America Organoids Market Segmentation, By Country
  • Figure 2. South & Central America - PEST Analysis
  • Figure 3. South & Central America Organoids Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. South & Central America Organoids Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. South & Central America Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • Figure 7. Stomach: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Intestine: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Liver: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Pancreas: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Lung: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Brain: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Kidney: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. South & Central America Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 16. Developmental Biology: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Disease Pathology of Infectious Disease: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Regenerative Medicine: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Drug Toxicity and Efficacy Testing: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Drug Discovery and Personalized Medicine: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. South & Central America Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 23. Pluripotent Stem Cells: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Organ-specific Adult Stem Cells: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. South & Central America Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 26. Instruments: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Consumables: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Services: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. South & Central America Organoids Market, By Country - Revenue (2022) ($Mn)
  • Figure 30. South & Central America Organoids Market, By Key Countries, 2022 and 2030 (%)
  • Figure 31. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Pre & Post COVID-19 Impact
  • Figure 35. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: BMIRE00028764

The South & Central America organoids market is expected to grow from US$ 132.38 million in 2022 to US$ 654.25 million by 2030. It is estimated to grow at a CAGR of 22.1% from 2022 to 2030.

Focus on Drug Discovery Activities Fuel South & Central America Organoids Market

The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2020 was estimated to be 356,282. A recent survey by the Hubrecht Institute states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models.

Further, organoids in drug discovery are not limited to just cancer, they are also used in other diseases, such as cystic fibrosis, polycystic kidney disease, microcephaly, and infectious diseases of the gut and airway. For instance, organoids can summarize the properties of an organ, such as organ structure and function. Also, organoids can restore a tissue or organ's original genetic and epigenetic state, making them suitable for gene editing. Various studies have shown positive results of combining CRISPR-Cas9 technology with organoids, which has expanded opportunities for breakthroughs in cystic fibrosis. According to a study 'CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank,' published in 2020, a biobank of cystic fibrosis intestinal organoids represented 664 patients, and ~20% of them were theoretically able to efficiently repair nonsense mutations in the cystic fibrosis transmembrane conductor receptor through adenine base editors. Despite a few achievements of gene-edited organoids in some animal models, their efficiency is significantly low, and the success rate is not high. Therefore, it is crucial to research and develop a process for gene-edited organoids' safety, long-term stability, and functionality.

Moreover, the COVID-19 pandemic triggered the need to develop human lung organoid models. For instance, MilliporeSigma developed a 3dGRO Human Lung Organoid Culture System that allows researchers to control, access, and reproduce organ tissue for culturing an organoid model of human lung epithelium that can aid in obtaining positive and successful results during their research. Thus, such innovations are expected to offer more significant growth opportunities for the market growth.

South & Central America Organoids Market Overview

The South & Central America organoids market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the increasing number of cancer cases, growing government initiatives, and rising research and development for organoids.

South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Organoids Market Segmentation

The South & Central America organoids market is segmented into organ type, type, application, Source, and country.

Based on organ type, the South & Central America organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the South & Central America organoids market in 2022.

Based on type, the South & Central America organoid market is segmented into instruments, consumables, and services. The consumables segment held the largest share of the North America organoid market in 2022.

Based on application, the South & Central America organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held largest share of the South & Central America organoids market in 2022.

Based on source, the South & Central America organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held the larger share of the South & Central America organoids market in 2022.

Based on country, the South & Central America organoids market is segmented into the Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America organoids market in 2022.

Cellesce, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc, are some of the leading companies operating in the South & Central America organoids market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America organoids market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South America organoids market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South America market trends and outlook coupled with the factors driving the organoids market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 South & Central America Key Insights
  • 2.2 South & Central America Market Attractiveness

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Organoids Market Landscape

  • 4.1 Overview
  • 4.2 South & Central America PEST Analysis

5. South & Central America Organoids Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 5.1.2 Growing Adoption of Personalized Drugs
    • 5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
  • 5.2 Key Market Restraints:
    • 5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
    • 5.2.2 Dearth of Skilled Professionals
  • 5.3 Key Market Opportunities:
    • 5.3.1 Focus on Drug Discovery Activities
  • 5.4 Future Trends:
    • 5.4.1 Combining Organoid with Organ-On-A-Chip
  • 5.5 Impact Analysis:

6. Organoids Market - South & Central America Market Analysis

  • 6.1 South & Central America Organoids Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Organoids Market - Revenue and Forecast to 2030 - by Organ Type.

  • 7.1 Overview
  • 7.2 South & Central America Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Intestine
    • 7.4.1 Overview
    • 7.4.2 Intestine: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Liver
    • 7.5.1 Overview
    • 7.5.2 Liver: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pancreas
    • 7.6.1 Overview
    • 7.6.2 Pancreas: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Lung
    • 7.7.1 Overview
    • 7.7.2 Lung: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Brain
    • 7.8.1 Overview
    • 7.8.2 Brain: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Kidney
    • 7.9.1 Overview
    • 7.9.2 Kidney: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Organoids Market - Revenue and Forecast to 2030 - by Application.

  • 8.1 Overview
  • 8.2 South & Central America Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Developmental Biology
    • 8.3.1 Overview
    • 8.3.2 Developmental Biology: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Disease Pathology of Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Disease Pathology of Infectious Disease: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Regenerative Medicine: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Drug Toxicity and Efficacy Testing
    • 8.6.1 Overview
    • 8.6.2 Drug Toxicity and Efficacy Testing: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Drug Discovery and Personalized Medicine
    • 8.7.1 Overview
    • 8.7.2 Drug Discovery and Personalized Medicine: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Organoids Market - Revenue and Forecast to 2030 - by Source.

  • 9.1 Overview
  • 9.2 South & Central America Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • 9.3 Pluripotent Stem Cells
    • 9.3.1 Overview
    • 9.3.2 Pluripotent Stem Cells: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Organ-specific Adult Stem Cells
    • 9.4.1 Overview
    • 9.4.2 Organ-specific Adult Stem Cells: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Organoids Market - Revenue and Forecast to 2030 - by Type

  • 10.1 Overview
  • 10.2 South & Central America Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • 10.3 Instruments
    • 10.3.1 Overview
    • 10.3.2 Instruments: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Consumables
    • 10.4.1 Overview
    • 10.4.2 Consumables: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Services
    • 10.5.1 Overview
    • 10.5.2 Services: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Organoids Market - Country Analysis

  • 11.1 South & Central America Organoids Market: Overview
    • 11.1.1 South & Central America Organoids Market by Country
      • 11.1.1.1 Brazil
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.1.3 Brazil Organoids Market, by Organ Type
        • 11.1.1.1.4 Brazil Organoids Market, by Application
        • 11.1.1.1.5 Brazil Organoids Market, by Source
        • 11.1.1.1.6 Brazil Organoids Market, by Type
      • 11.1.1.2 Argentina
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.3 Argentina Organoids Market, by Organ Type
        • 11.1.1.2.4 Argentina Organoids Market, by Application
        • 11.1.1.2.5 Argentina Organoids Market, by Source
        • 11.1.1.2.6 Argentina Organoids Market, by Type
      • 11.1.1.3 Rest of South & Central America
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.3 Rest of South & Central America Organoids Market, by Organ Type
        • 11.1.1.3.4 Rest of South & Central America Organoids Market, by Application
        • 11.1.1.3.5 Rest of South & Central America Organoids Market, by Source
        • 11.1.1.3.6 Rest of South & Central America Organoids Market, by Type

12. Pre & Post COVID-19 Impact

  • 12.1 Pre & Post COVID-19 Impact

13. South & Central America Organoids Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. South & Central America Organoids Market, Key Company Profiles

  • 14.1 STEMCELL Technologies Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Cellesce Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Thermo Fisher Scientific Inc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Merck KGaA
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 InSphero
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms